Imprivata OneSign
Simple and secure access management for mission-critical industries
Est 2000|Valuation $492.5M|Raised $2.6B
Platform CoversPrivileged Access Management (PAM)
Simple and secure access management for mission-critical industries
Published Jul 9, 2026
Product roadmaps are not public in detail; prospective buyers typically request roadmap briefings under NDA.
No hard public thresholds were identified in open sources; practical constraints will be environment-specific (VDI sizing, profile complexity, number of endpoints, and integration scope).
TrustRadius lists Imprivata Enterprise Access Management (formerly OneSign & Confirm ID) with a modest number of reviews and corroborates that the product is commonly referred to as EAM in market-facing materials.
Gartner Peer Insights contains customer reviews that highlight operational benefits in clinical settings (reduced repeated password entry) alongside notes about operational overhead, particularly around agent maintenance.
Community forums and sysadmin threads provide candid operational feedback, including troubleshooting experiences with browser behavior, thin-client integration, and perceived cost concerns for limited-scope use cases.
Reported churn drivers and dissatisfaction signals include:
The vendor publishes metrics such as claims of reduced login time during shifts. These metrics are vendor-provided and frequently lack publicly disclosed methodologies (e.g., details on sample size, baseline definitions, and measurement methods). Treat these figures as directional until validated via customer references or independent time-and-motion studies.
Vendor- or partner-published case studies commonly describe reduced login friction, improved clinician experience, and improved audit/compliance posture. Typical gaps in such case studies include limited disclosure of total project cost and cost breakdowns, incomplete measurement methodology, and a lack of detailed discussion of operational negative outcomes such as downtime or upgrade issues.
Decision makers:
End users:
Primary deployments are in hospitals, health systems, outpatient clinics, and other regulated healthcare providers where clinicians use shared endpoints and must access EHRs quickly (Epic, Cerner, MEDITECH, etc.). The vendor also promotes the product for some regulated/mission-focused sectors (government, finance), but the most developed ecosystem and product-market fit is in healthcare.
Get a comprehensive analysis of Imprivata OneSign including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Positive themes reported by reviewers include time savings, convenience, and multiple authentication methods. Some reviewers describe fast initial setup in clinical contexts.
Negative themes include administrative enrollment limitations, support responsiveness, and user interface/navigation concerns. Multiple reviewers report enrollment workflow limitations (difficulty sending registration links/QR codes or enrolling methods incrementally) and mixed feedback on support responsiveness and browser compatibility in legacy deployments.
Imprivata OneSign (marketed within Imprivata Enterprise Access Management, EAM) is an enterprise single sign-on and authentication platform designed to reduce repeated password entry in shared workstation and virtual desktop (Citrix/VMware) environments while improving access controls and auditability. It supports badge, biometric, and proximity-card authentication and provides fast user switching and automatic locking behavior for clinical settings.
Vendor positioning includes:
(Official positioning and feature claims are documented across EAM and OneSign pages and product collateral.)